Animal and cell studies
The published evidence is from animals and cells. Little or nothing is published from controlled trials in people.
This page is a stub
The wiki has this compound's identity from the My-Pepts library, its standing, and what PubMed holds for it. The article, with its studies read and cited, is not written yet. Until it is, the counts below say how much research exists, not what it found.
How strong is the evidence
How far it has climbed
Every medicine climbs the same ladder. Most compounds never reach the top, and where one stands says how much its claims can carry.
- Licensed medicine
A regulator has reviewed the trials and licensed it for a named use.
- Phase 3
Large randomized trials, often thousands of people, against placebo or a standard treatment.
- Phase 2
Mid-sized trials that measure dose against effect in people with the condition.
- Phase 1 and early human studies
First studies in people: safety, and how the body handles it.
- Cells and animals: N-Acetyl Semax Amidate
Laboratory and animal work. An animal result is not a result in people.
- 210
- papers on PubMed
- 49
- of them in people
- 1
- randomized trials
- 11
- reviews
A count says how much has been published, not what it found. Counted on PubMed: 2026-11-16
Handling and reconstitution
From powder to a measured sample
The same four steps for any lyophilized vial. Laboratory handling, not use in a person.
1. Read the vial
The label gives the mass of peptide in the vial, in milligrams. That number is the start of every calculation.
2. Add the diluent
A measured volume of diluent goes in slowly, down the glass. Swirl gently; shaking can damage a peptide.
3. Work out the strength
Concentration is mass divided by volume: 10 mg in 2 mL is 5 mg per mL.
4. Measure the sample
Volume is the mass wanted divided by the concentration. On a U-100 syringe, 1 mL is 100 units.
The calculator below does the arithmetic and shows its working.
As powder
General practice for lyophilized peptides: keep the sealed vial frozen or refrigerated, dry and away from light, and follow the supplier's certificate of analysis.
In solution
Once in solution a peptide is kept refrigerated and used within the period the supplier states. A vial drawn from more than once needs a preserved diluent such as bacteriostatic water.
This is general practice for lyophilized peptides, not data on N-Acetyl Semax Amidate itself. The batch's certificate of analysis and the supplier's sheet are the facts to go by. More on storage
Reconstitution calculator
Opens on vial sizes common for research peptides. Change any number. How the arithmetic works
Draw to
10 units
0.1 mL on a U-100 syringe
- Concentration
- 2.5 mg/mL
- Each unit holds
- 25 mcg
- Samples in the vial
- 20
- Sample
- 250 mcg
5 mg in 2 mL is 2.5 mg/mL. 250 mcg of that is 0.1 mL, which reads as 10 units. This is arithmetic for a vial of N-Acetyl Semax Amidate; no amount here is a recommendation.
N-Acetyl Semax Amidate: on PubMed
What PubMed held for N-Acetyl Semax Amidate on November 16, 2026. A count says how much a compound has been studied, not what the studies found: how to read these numbers.
- 210
- papers
- 49
- in humans
- 4
- clinical trials
- 1
- randomized trials
Most relevant on PubMed
Listed by PubMed's own relevance ranking, trials and reviews first. The wiki has not read these into the article unless they are also among its sources.
- [The efficacy of semax in the tretament of patients at different stages of ischemic stroke]
TrialGusev EI, Martynov MY, Kostenko EV, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2018. PMID 29798983
- [Effectiveness of semax in acute period of hemispheric ischemic stroke (a clinical and electrophysiological study)]
TrialGusev EI, Skvortsova VI, Miasoedov NF, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 1997. PMID 11517472
- [Evaluation of therapeutic effect of new Russian drug semax in optic nerve disease]
TrialPolunin GS, Nurieva SM, Baiandin DL, et al. Vestnik oftalmologii, 2000. PMID 10741256
- [The study of chronic partial denervation and quality of life in patients with motor neuron disease treated with semax]
Randomized trialSerdiuk AV, Levitskiĭ GN, Miasoedov NF, et al. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2007. PMID 18379501
- Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions
ReviewRahman OF, Lee SJ, Seeds WA Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews, 2026. PMID 41490200
- Functional Connectomic Approach to Studying Selank and Semax Effects
StudyPanikratova YR, Lebedeva IS, Sokolov OY, et al. Doklady biological sciences : proceedings of the Academy of Sciences of the USSR, Biological sciences sections, 2020. PMID 32342318
- Therapeutic peptides in gerontology: mechanisms and applications for healthy aging
ReviewMavrych V, Shypilova I, Bolgova O Frontiers in aging, 2026. PMID 42021992
- Semax peptide targets the μ opioid receptor gene Oprm1 to promote deubiquitination and functional recovery after spinal cord injury in female mice
StudyLiu R, Chen Y, Huang H, et al. British journal of pharmacology, 2025. PMID 40692165
Search used: (semax[tiab]). Run it on PubMed
Research links
- PubMed (opens in a new tab)Every indexed paper, newest first
- ClinicalTrials.gov (opens in a new tab)Registered trials and their status
- Europe PMC (opens in a new tab)Full text where it is open access
- Google Scholar (opens in a new tab)Papers, preprints and who cites them
- PubChem (opens in a new tab)Structure, identifiers and properties
- YouTube (opens in a new tab)Talks and lectures. Check who is speaking
These open a search for N-Acetyl Semax Amidate on each site. The wiki has not reviewed what they return: a video or a preprint is not a peer-reviewed result, and none of it is medical advice.